Literature DB >> 1428574

Mitomycine, suterelysis and hypotony.

H C Geijssen1, E L Greve.   

Abstract

In 35 patients 37 trabeculectomies (TE) were performed using mitomycin as a fibrosisinhibitor. Mitomycin (0.5 mg/ml) was applied to the sclera (under the scleral flap) and conjunctiva in the area of the projected TE during 5 minutes using a small sponge. The indications for operation were: visual field progression in 15 eyes, too high IOP in 13 eyes and severe visual field defects (central island and/or centro coecal visual field defects) in 9 eyes. Six patients had Normal Pressure Glaucoma, 17 Primary Open Angle Glaucoma and 12 had other forms of glaucoma. There were 22 first TE's and 15 re-operations. The scleral flap was sutured with 5 to 8 10/0 nylon sutures. The system of a large number of sutures and subsequent suturelysis was our routine management for reducing complications after TE. This report deals with the postoperative period of the first three months. Suturelysis in combination with mitomycine caused an unexpected high number of postoperative hypotonies (IOP < = 6 mmHg with reduced visual acuity and/or retinal folds or large persistent choroidal detachment and shallow anterior chamber) In the 27 eyes who had suturelysis performed, 7 developed a hypotony. The hypotony may develop as late as three weeks postoperative after suturelysis!. Two eyes developed a hypotony without suturelysis. Seven patients needed resuturing of the scleral flap. The use of mitomycine to enhance filtration after TE may cause serious hypotonies if the scleral flap is not securely closed and if suturelysis is used too early or too extensively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428574     DOI: 10.1007/bf00917994

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  13 in total

1.  Results of a filtering procedure in low tension glaucoma.

Authors:  N de Jong; E L Greve; P F Hoyng; H C Geijssen
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

2.  Management of failing filtering blebs with the Argon laser.

Authors:  H D Hoskins; C Migliazzo
Journal:  Ophthalmic Surg       Date:  1984-09

3.  Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery.

Authors:  G L Skuta; C C Beeson; E J Higginbotham; P R Lichter; D C Musch; T J Bergstrom; T B Klein; F Y Falck
Journal:  Ophthalmology       Date:  1992-03       Impact factor: 12.079

4.  Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma.

Authors:  C W Chen; H T Huang; J S Bair; C C Lee
Journal:  J Ocul Pharmacol       Date:  1990

5.  Mitomycin as adjunct chemotherapy with trabeculectomy.

Authors:  S S Palmer
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

6.  Glaucoma filtering surgery: factors that determine pressure control.

Authors:  R Z Levene
Journal:  Ophthalmic Surg       Date:  1984-06

7.  Trabeculectomy in young patients.

Authors:  M G Gressel; D K Heuer; R K Parrish
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

8.  Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma.

Authors:  J M Liebmann; R Ritch; M Marmor; J Nunez; B Wolner
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

9.  Fluorouracil Filtering Surgery Study one-year follow-up. The Fluorouracil Filtering Surgery Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1989-12-15       Impact factor: 5.258

10.  Initial 5-fluorouracil trabeculectomy in young patients.

Authors:  J Whiteside-Michel; J M Liebmann; R Ritch
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

View more
  2 in total

1.  Prevention of hypotony after trabeculectomies with mitomycin.

Authors:  H C Geijssen; E L Greve
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

2.  Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.

Authors:  Masoumeh B Masoumpour; M Hossein Nowroozzadeh; M Reza Razeghinejad
Journal:  Open Ophthalmol J       Date:  2016-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.